Emily Woodworth - 03 Mar 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
SVP, Global Controller and CAO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
03 Mar 2025
Net transactions value
-$577,809
Form type
4
Filing time
05 Mar 2025, 16:16:17 UTC
Previous filing
03 Mar 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $223,088 +5,949 +281% $37.50 8,063 03 Mar 2025 Direct F1
transaction BSX Common Stock Sale $750,465 -7,149 -89% $104.97 914 03 Mar 2025 Direct F1, F2
transaction BSX Common Stock Sale $50,432 -482 -53% $104.63 432 04 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -5,949 -71% $0.000000 2,383 03 Mar 2025 Common Stock 5,949 $37.50 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024.
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.85 to $105.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.